CompletedNot Applicable

Development of an Optimal Algorithm for the Management of Patients With Retinal Pigment Epithelium Detachment in Neovascular Age-related Macular Degeneration Using Artificial Intelligence

Russia300 participantsStarted 2021-11-01

Plain-language summary

The study involves the development of an algorithm for predicting anatomical and functional results of therapy with angiogenesis inhibitors in patients with retinal pigment epithelium detachments in neovascular age-related macular degeneration, based on primary optical coherence tomography of the macular zone and clinical data.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria: * Linear B - scan through the macular area with the longest detachment * Other pathologies Exclusion criteria: * Images without detachment * Images on which it is possible to diagnose the need for therapy only in the presence of additional factors not considered in the study.

What they're measuring

Prediction algorithm

Timeframe: 1.09.2022

Trial details

NCT IDNCT05208931

SponsorThe S.N. Fyodorov Eye Microsurgery State Institution

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2022-09-01

View on ClinicalTrials.gov More Neovascular Age-related Macular Degeneration trials